Global Prenatal Screening Tests (In Vitro Diagnostics) Market Report 2020: Analysis and Forecast Model with COVID-19 Market Impact 2015-2030 – ResearchAndMarkets.com

Global Prenatal Screening Tests (In Vitro Diagnostics) Market Report 2020: Analysis and Forecast Model with COVID-19 Market Impact 2015-2030 – ResearchAndMarkets.com




Global Prenatal Screening Tests (In Vitro Diagnostics) Market Report 2020: Analysis and Forecast Model with COVID-19 Market Impact 2015-2030 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Prenatal Screening Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 Market Impact)” report has been added to ResearchAndMarkets.com’s offering.

The model discusses in detail the impact of COVID-19 on Prenatal Screening tests market for the year 2020 and beyond.

In most countries, maternal serum screening and ultrasound remain standard-of-care for screening of pregnant women for chromosome aneuploidies and other birth defects. If these tests are positive, then prenatal diagnosis is typically performed via either amniocentesis or chorionic villus sampling (CVS). However, both amniocentesis and CVS are invasive techniques that have a risk of fetal death and miscarriage.

NIPT is available in more than 60 countries; it is considered more sensitive and represents an attractive alternative to both maternal serum screening and invasive follow-up diagnostic techniques.

NIPT is performed using cell-free DNA from maternal blood, which is amplified and sequenced. Due to the sequencing process, NIPT it more expensive than maternal serum screening methods and this represents a major barrier in its widespread clinical adoption.

Companies covered:

  • Illumina, Inc.
  • Danaher Corp
  • Ortho-Clinical Diagnostics Inc
  • F. Hoffmann-La Roche Ltd
  • Eurofins Scientific
  • BGI Genomics

Key Inclusions of the market model are:

Currently marketed Prenatal Screening tests and evolving competitive landscape

  • Insightful review of the key industry trends.
  • Annualized total Prenatal Screening tests market revenue by segment and market outlooks from 2015-2030.
  • Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition, analysts provide unique country specific insights on the market.
  • SWOT analysis for Prenatal Screening tests market.
  • Competitive dynamics insights and trends provided for Prenatal Screening tests market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Scope

  • CMO executives who must have deep understanding of the Prenatal Screening tests marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

  • Understand the impact of COVID-19 on Prenatal Screening tests market.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving Prenatal Screening tests market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Prenatal Screening tests market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Prenatal Screening tests market from 2015-2030.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

For more information about this report visit https://www.researchandmarkets.com/r/3lyq3a.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T. Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900